Author:
Hirschfeldova Katerina,Florianova Martina,Kebrdlova Vera,Urbanova Marketa,Stekrova Jitka
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference17 articles.
1. Gatta, V., Palka, C., Chiavaroli, V., Franchi, S., Cannataro, G., Savastano, M. et al. Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer region. BMC Med. Genet. 15, 87 (2014).
2. Jorge, A. A., Souza, S. C., Nishi, M. Y., Billerbeck, A. E., Liborio, D. C., Kim, C. A. et al. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability. Clin. Endocrinol. (Oxf.) 66, 130–135 (2007).
3. Munns, C. J., Haase, H. R., Crowther, L. M., Hayes, M. T., Blaschke, R., Rappold, G. et al. Expression of SHOX in human fetal and childhood growth plate. J. Clin. Endocrinol. Metab. 89, 4130–4135 (2004).
4. Clement-Jones, M., Schiller, S., Rao, E., Blaschke, R. J., Zuniga, A., Zeller, R. et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum. Mol. Genet. 9, 695–702 (2000).
5. Fukami, M., Kato, F., Tajima, T., Yokoya, S. & Ogata, T. Transactivation function of an approximately 800-bp evolutionarily conserved sequence at the SHOX 3′ region: implication for the downstream enhancer. Am. J. Hum. Genet. 78, 167–170 (2006).